General Considerations
Physical treatments such as electrical neurostimulation have clear advantages over pharmacotherapy in terms of adverse side effects.
Despite this and the fact that fewer than half of patients with chronic neuropathic pain obtain worthwhile long-term pain relief from drugs, 4 implanted neurostimulators are regarded as a treatment of last resort. This is only partly due to the high initial cost involved; cost-effectiveness studies are consistently positive, with a crossover point in less than three years 5 (probably a little later, but with greater long-term benefit, in the case of the more expensive recently introduced rechargeable systems).
The biggest hurdle facing the field is the issue of evidence. There is a large body of positive but uncontrolled published evidence and enormous unpublished positive experience, but very little 'level one' evidence. Not only does this provide the financially constrained healthcare commissioners and insurers with an excuse, but it is also relevant to the key factor of case selection.
There are remarkably few contraindications: the presence of an implanted cardiac defibrillator or a demand-type cardiac pacemaker, uncontrolled coagulopathy, sepsis and, to a variable extent, cognitive impairment.
Spinal Cord Stimulation

General Comments
This is the most widely and commonly used form of internal neurostimulation. The epidural electrodes are placed ipsilateral to the pain, because it is necessary to activate the collaterals of the large Aß afferents that ascend in the posterior columns of the spinal cord. The rostro-caudal and lateral positioning of the electrode system must be appropriate so that the gentle evoked paraesthesiae cover the painful area. Originally, monopolar systems were used, then bipolar and now 16 contacts are commonly available, requiring computer assistance for programming. Dual-channel and multichannel programming permit electronic steering of the stimulation topography, greatly reducing the need for physical repositioning of the electrodes. Electrodes are either of the wire/catheter type, which can be inserted percutaneously via a Tuohy needle under local anaesthesia or in the form of a paddle, which requires an open operation. The former are less invasive but are electrically inefficient and more prone to dislodgement than 'surgical' systems. The latter perform better but require both a surgeon and a bigger procedure for insertion. The power comes from an implanted pulse generator similar to a cardiac pacemaker and the electronic parameters are programmed by telemetry. External power sources coupled to an implanted receiver-transducer by radiofrequency are available for cases in which power demand is high, but the recent introduction of rechargeable implantable systems avoids the need for frequent replacements in a more elegant way.
Indications
In broad terms, SCS is effective for neuropathic and ischaemic pain and does not influence nociceptive pain (e.g. arthritis, acute wound pain, etc.). 6 The most common applications, which have also provided the best evidence for efficacy, are complex regional pain syndrome (CRPS) and the poorly named failed back surgery syndrome (FBSS). FBSS, i.e. pain in the leg and/or back persisting after one or more lumbar spine operations, is One demonstrated superiority of SCS over re-operation 7 and the other supported the addition of SCS over conventional medical management alone. 8 Overall, the success rate appears to be around 60-65%.
CRPS, characterised by severe pain, allodynia and autonomic, trophic and motor abnormalities following almost any injury (type I) or a specific nerve injury (type II), also responds well to SCS. A significant degree of pain relief occurs in approximately 70% of cases and the allodynia (pain induced by normally innocuous stimuli) and other elements are also often normalised.
CRPS remains poorly understood and even its classification as a neuropathic syndrome is controversial. 9 The biggest puzzle is why it should develop after one particular injury, having not emerged previously in the same (predisposed) individual. One published RCT showed a significantly greater degree of pain relief when SCS was added to physiotherapy. 10 A large body of less robust published evidence also supports the use of 
Mechanism of Action
The relative contributions of long-loop effects via the brainstem and of the mechanism of action will improve both case selection and the credibility of the treatment in the eyes of commissioners and reimbursers.
It may also shed light on the pathophysiology of the conditions it modifies.
Other Methods of Neurostimulation
Motor Cortex Stimulation
The relationship between sensory and motor functions is complex and fundamental, and there must be a point in cerebral activity at which the distinction is lost. It is therefore fascinating to reflect on the fact that stimulating the motor cortex with surface (epidural) electrodes 15 Neuropathic Pain by trial stimulation. Reported outcomes have varied quite widely, but the long-term success rate has been lower for neuropathic pain than for nociceptive pain and has not exceeded 50%. 11, 16, 18 An apparent exception is the recently introduced hypothalamic stimulation for cluster headache, which appears to have a much higher success rate. 19 In general, neuropathic pain of peripheral origin has fared better with DBS than has central (post-stroke) pain.
Peripheral Nerve Stimulation
Peripheral 
Sacral Root Stimulation
Sacral motor (ventral) root stimulation has been used for three decades to improve bladder and erectile function in paraplegics. It is only recently, however, that the therapeutic value of sacral sensory root stimulation has been appreciated, particularly for interstitial cystitis and urge incontinence.
The published evidence remains sparse but encouraging at present and the techniques are relatively simple, without the need for major surgery. 22 
Conclusion
As 
